AsianScientist reported on the continuous advancements in medical science, with new treatment modalities being researched and introduced rapidly, including for complex diseases like diffuse large B-cell lymphoma (DLBCL). The standard of care for relapsed or refractory DLBCL typically involves intensive treatments such as chemotherapy and haematopoietic stem cell transplantation. Researchers are working on innovative approaches to improve outcomes for patients with this aggressive blood cancer.
Full Article
Late-stage VC rebound in Southeast Asia will take time: Meet Capital’s John Lim
Meet Capital, a new early-stage VC firm affiliated with Meet Ventures, is deploying a US$10 million fund to back tech-enabled startups with cheques up to US$500,000. Led by General Partner John Lim, the firm focuses on startups with product-market fit and a billion-dollar market opportunity, primarily in Southeast Asia but open to global opportunities. Despite challenges in the VC industry in Southeast Asia, Meet Capital remains optimistic about the region's growth potential and aims to...
Read more